• 제목/요약/키워드: Granulocyte-colony stimulating factor(G-CSF)

검색결과 113건 처리시간 0.024초

호중구 감소증을 유도한 마우스에서의 유전자 재조합 인과립구 콜로니자극인자의 효과 (Effects of Recombinant truman Granulocyte Colony-Stimulating Factor(rhG-CSF) on Cyclophosphamide-induced Neutropenic Mice)

  • 조명행;유아선;방명주;곽형일;성하정;안길환
    • Biomolecules & Therapeutics
    • /
    • 제6권2호
    • /
    • pp.145-150
    • /
    • 1998
  • Administration of 3 type KGCs [recombinant human granulocyte colony-stimulating factor (rhG-CSF)] to mice with cyclophosphamide (CPA)-induced neutropenia for 4 consecutive days from the day after the CPA dosing (100 mg/kg) resulted in a dose dependent increase in the peripheral blood neutrophil count 6 hours after the final KGC injection. Within the KGC dose range of 0.1 to 40$\mu$g Per mouse Per day, there was a sigmoidal relationship between the logarithm of the dose and the peripheral blood neutrophil count (relative value for neutrophil count of the basal dose) in the treated mice. The sigmoidal relationship of test KGC preparations shows that there is a saturation point in terms of efficacy. Compared with e(fact of KGC-Orange, Green, and Blue, KGC-Orange recovers neutrophils more effectively than the others do.

  • PDF

마우스 염증성 장 질환 모델에서 G-CSF (Granuocyte Colony Stimulating Factor)에 의한 염증 완화 (Granulocyte Colony Stimulating Factor (G-CSF) Attenuates 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-induced Colitis in Mice)

  • 최은영;전창덕;오재민;김유림;이수택;김상욱
    • IMMUNE NETWORK
    • /
    • 제6권1호
    • /
    • pp.13-19
    • /
    • 2006
  • Background: Granulocyte colony stimulating factor (G-CSF) is known as a cytokine central to the hematopoiesis of blood cells and to modulate their cellular functions. Besides granulocytes and their precursors, monocytes/macrophages and endothelial cells are direct target cells of G-CSF action. G-CSF influences immune cells in an anti inflammatory way. Methods: To evaluate whether G-CSF has a potential for preventing or ameliorating diseases characterized by mucosal inflammation, we used a mouse model with trinitrobenzene sulfonic acid (TNBS)-induced inflammatory colitis. To the mice model G-CSF was administrated daily by intraperitoneal injection. Macroscopic evaluation and immunohistochemical analysis of colonic tissues were performed. Results: Re combinant human G-CSF significantly inhibited LPS-induced TNF-${\alpha}$ mRNA expression in THP-1 cells. As for in vivo relevance, G-CSF dramatically reduced the weight loss of mice, colonic damage, and mucosal ulceration that characterize TNBS colitis. Moreover, G-CSF suppressed the expression of tumor necrosis factor-${\alpha}$, interleukin-$1{\beta}$, and intercellular adhesion molecule-1 in TNBS colitis. Conclusion: Current results demonstrate that G-CSF may be an effective agent for the treatment of diseases characterized by mucosal inflammation.

CJ-50001 (recombinant human granulocyte-colony stimulating factor)의 흰쥐와 개에서의 약물동태학적 연구 (Pharmacokinetics of CJ-50001i Recombinant Human Granulocyte-Colony Stimulating Factor, in Rats and Dogs)

  • 김성남;신재규;이수정;정용환;하석훈;김기완;고형곤;김제학
    • Biomolecules & Therapeutics
    • /
    • 제6권4호
    • /
    • pp.400-405
    • /
    • 1998
  • The pharmacokinetics of CJ-50001 (recombinant human granulocyte-colony stimulating factor, developed by R&D center of Cheil Jedang Corp.) were investigated in rats and dogs. The serum concentrations of CJ-50001 were measured by a sandwich enzyme immunoassay. After single intravenous (iv) administration of Cf-50001 to rats at a dose of 5 $\mu$g/kg, the mean terminal half-life and area under the concentration-time curve (AUC) were 0.96 h and 124.497g . h/ml, respectively. After single subcutaneous (sc) administration at the same dose, maximum serum concentration was observed at about 2 hours after administration, and the mean terminal half-life, AUC and the bioavailability were 1.11 h,63.58$\mu$g . h/ml and 51.07%, respectively. In repeated dosing studies, CJ-50001 was administered iv and sc to rats at a daily dose of 5$\mu$g/kg for 7 days. The pharmacokinetic parameters, such as mean AUC and terminal half-life, were no significantly different from those of single administration. Following single iv and sc administration of CJ-50001 to dogs at a dose of 5 $\mu$g/kg, mean AUCs were much higher than those of rats, due to the decreased clearence (CL). After sc administration to dogs, maximum serum concentration was observed at 2~4 hours after administration and the bioavailability was 54.60%.

  • PDF

누에세포를 이용한 인간 G-CSF의 발현 및 생산 (Expression and Production of Human Granulocyte Colony Stimulating Factor (G-CSF) in Silkworm Cell Line)

  • 박정혜;장호정;강석우;구태원;정경태
    • 생명과학회지
    • /
    • 제20권11호
    • /
    • pp.1577-1581
    • /
    • 2010
  • 조혈촉진 cytokine인 Granulocyte colony stimulating factor (G-CSF)는 골수세포를 자극하여 granulocyte로 증식, 분화시키는 기능을 가지며, 현재 아주 고가의 치료제로 사용되고 있다. 인간 G-CSF (hG-CSF)를 아직 시도되지 않은 누에 유래 세포주인 BM5 세포에서 발현시키고 생산 효율을 높이기 위해 hG-CSF cDNA를 변형하였다. hG-CSF의 cDNA의 endoplasmic reticulum (ER) signal sequence 부분을 누에의 소포체에서 분비되는 단백질인 prophenoloxidase (PPAE), protein disulfide isomerase (PDI)와 bombyxin (BX)에서 유래한 누에특이 ER signal sequence로 대체한 hG-CSF의 cDNA 함유 벡터를 구축하였다. 이들 벡터를 사용하여 형질전환한 BM5 세포의 배양액에 분비된 G-CSF 단백질을 western blot으로 분석하여 발현을 확인하였다. 누에특이 ER signal sequence들로 대체된 hG-CSF cDNA를 포함하는 벡터에 의한 hG-CSF 단백질 생산이 인간 G-CSF cDNA가 든 벡터에 의한 hG-CSF의 생산보다 월등히 효율적이었다. 또한, PPAE-signal sequence를 포함하는 hG-CSF 단백질은 배양배지에서 형질전환 4일 후에 최고에 달하였고, 7 일째까지 비슷한 양이 배지 내에서 검출되었다. 이상의 결과는 인간유래 유전자가 곤충세포 내에서 발현 될 때 인간유래 유전자 보다는 곤충 유전자발현 시스템에 맞게 변형했을 경우 더 효율적인 단백질 발현을 얻을 수 있음을 보여 준다.

The efficacy of intrauterine instillation of granulocyte colony-stimulating factor in infertile women with a thin endometrium: A pilot study

  • Lee, Dayong;Jo, Jae Dong;Kim, Seul Ki;Jee, Byung Chul;Kim, Seok Hyun
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제43권4호
    • /
    • pp.240-246
    • /
    • 2016
  • Objective: The study aimed to investigate the efficacy of intrauterine instillation of granulocyte colony-stimulating factor (G-CSF) on the day of ovulation triggering or oocyte retrieval in infertile women with a thin endometrium. Methods: Fifty women whose endometrial thickness (EMT) was ${\leq}8mm$ at the time of triggering during at least one previous in vitro fertilization (IVF) cycle and an index IVF cycle were selected. On the day of triggering (n = 12) or oocyte retrieval (n = 38), $300{\mu}g$ of G-CSF was instilled into the uterine cavity. Results: In the 50 index IVF cycles, the mean EMT was $7.2{\pm}0.6mm$ on the triggering day and increased to $8.5{\pm}1.5mm$ on the embryo transfer day (p< 0.001). The overall clinical pregnancy rate was 22.0%, the implantation rate was 15.9%, and the ongoing pregnancy rate was 20%. The clinical pregnancy rate (41.7% vs. 15.8%), the implantation rate (26.7% vs. 11.7%), and the ongoing pregnancy rate (41.7% vs. 13.2%) were higher when G-CSF was instilled on the triggering day than when it was instilled on the retrieval day, although this tendency was likewise not statistically significant. Aspects of the stimulation process and mean changes in EMT were similar in women who became pregnant and women who did not. Conclusion: Intrauterine instillation of G-CSF enhanced endometrial development and resulted in an acceptable pregnancy rate. Instillation of G-CSF on the triggering day showed better outcomes. G-CSF instillation should be considered as a strategy for inducing endometrial growth and good pregnancy results in infertile women with a thin endometrium.

Production of Soluble Human Granulocyte Colony Stimulating Factor in E. coli by Molecular Chaperones

  • PARK SO-LIM;SHIN EUN-JUNG;HONG SEUNG-PYO;JEON SUNG-JONG;NAM SOO-WAN
    • Journal of Microbiology and Biotechnology
    • /
    • 제15권6호
    • /
    • pp.1267-1272
    • /
    • 2005
  • The effects of coexpression of GroEL/ES and DnaK/DnaJ/GrpE chaperones on the productivity of the soluble form of human granulocyte colony stimulating factor (hG-CSF) in E. coli were examined. Recombinant hG-CSF protein was coexpressed with DnaK/DnaJ/GrpE or GroEL/ES chaperones under the control of the araB or Pzt-1 promoter, respectively. The optimal concentration of L-arabinose for the expression of DnaK/DnaJ/GrpE was found to be 1 mg/ml. When L-arabinose was added at $OD_{600}$=0.2 (early-exponential phase), soluble hG-CSF production was greatly increased. In addition, it was observed that the DnaK/DnaJ/GrpE and GroEL/ES chaperones had no synergistic effects on preventing aggregation of hG-CSF protein. Consequently, by coexpression of the DnaK/DnaJ/GrpE chaperone, the signal intensity of the hG-CSF protein band in the soluble fraction of cell lysate was increased from $3.5\%\;to\;13.9\%$, and Western blot analysis also revealed about a 4-5-fold increase of production of soluble hG-CSF over the non-induction case of DnaK/DnaJ/GrpE.

Plasmid Stability in Long-Term hG-CSF Production Using $_{L}-Arbinose$ Promoter System of Escherichia coli

  • Choi, Seung-Jin;Park, Doo-Hong;Chung, Soo-Il;Jung, Kyung-Hwan
    • Journal of Microbiology and Biotechnology
    • /
    • 제10권3호
    • /
    • pp.321-326
    • /
    • 2000
  • To examine the feasibility of the long-term production of the human granulocyte colony stimulating factor (hG-CSF) using the $_{L}-arabinose$ promoter system of Escherichia coli, flask relay culture and cyclic fed-batch culture were performed. In the flask relay culture, it was found that the pismid was maintained stably up to about 170 generations in an uninduced condition, whereby the cells could also maintain the capability of expressing hG-CSF expression were maintained stably up to at least 100 generations. In contrast, in the cyclid fed-batch culture, segregational plasmid instability was observed within about 4 generations after induction, even though the cell growth and hG-CSF production reached their maximum balues, 78.0 g/l of dry cell weight and 7.0 g/l of hG-CSF, respectively. It would appear that, when compared to the flask relay culture, the high-cell density and high-level expression of hG-CSF in the cyclic fed-batch cultrure led to the segregational plasmid instability; in other words, a severe metabolic burden existe on the cells due to the high-level expression of hG-CSF. Accordingly, based on these long-term cultures, the segregational and structural plasmid instability was observed and a strategy to overcome such problems could be designed.

  • PDF

마우스 대식세포를 이용한 일당귀 물추출물의 항염효능 연구 (Anti-inflammatory Effect of Angelicae acutilobae Radix Water Extract on LPS-stimulated Mouse Macrophages)

  • 한효상
    • 대한본초학회지
    • /
    • 제28권6호
    • /
    • pp.129-133
    • /
    • 2013
  • Objectives : The purpose of this study was to investigate the effects of Angelicae acutilobae Radix Water Extract (AA) on the production of cytokines in RAW 264.7 cell stimulated with lipopolysaccharide (LPS). Method : RAW 264.7 cells were cotreated with AA (50 and $100{\mu}g/mL$) and lipopolysaccharide (LPS; $1{\mu}g/mL$) for 24 hours. After 24 hours treatment, using bead-based multiplex cytokine assay, concentrations of various cytokines such as interleukin(IL)-6, tumor necrosis factor-alpha(TNF-${\alpha}$) granulocyte colony-stimulating factor(G-CSF), granulocyte macrophage colony-stimulating factor(GM-CSF), and macrophage inflammatory protein(MIP)-$1{\alpha}$ were measured. Result : AA significantly inhibited LPS-induced production of IL-6 and MIP-$1{\alpha}$ from LPS-stimulated RAW 264.7 cells at the concentration of $50{\mu}g/mL$. AA significantly inhibited LPS-induced production of TNF-${\alpha}$ from LPS-stimulated RAW 264.7 cells at the concentration of $100{\mu}g/mL$. AA significantly inhibited LPS-induced production of G-CSF and GM-CSF in RAW 264.7 cells at the concentrations of 50 and $100{\mu}g/mL$. Conclusion : These results suggest that AA has anti-inflammatory effect related with its inhibition of proinflammatory cytokines such as IL-6, TNF-${\alpha}$, G-CSF, GM-CSF, and MIP-$1{\alpha}$ in LPS-induced macrophages.

Lipopolysaccharide로 유발된 마우스 대식세포의 염증매개성 Cytokine 생성증가에 대한 참당귀 물추출물의 효능 연구 (Anti-inflammatory Effect of Angelicae Gigantis Radix Water Extract on LPS-stimulated Mouse Macrophages)

  • 한효상
    • 대한본초학회지
    • /
    • 제28권5호
    • /
    • pp.113-119
    • /
    • 2013
  • Objectives : The purpose of this study was to investigate the effects of Angelicae Gigantis Radix Water Extract(AG) on the production of proinflammatory mediators in RAW 264.7 cells stimulated with lipopolysaccharide(LPS). Method : RAW 264.7 cells were cotreated with AG(50 and 100 ug/mL) and lipopolysaccharide(LPS; 1 ug/mL) for 24 hours. After 24 hour treatment, using Bead-based multiplex cytokine assay, concentrations of various cytokines such as interleukin(IL)-6, IL-$1{\beta}$, IL-10, tumor necrosis factor-alpha(TNF-${\alpha}$), granulocyte colony-stimulating factor(G-CSF), granulocyte macrophage colony-stimulating factor(GM-CSF), interferon inducible protein-10(IP-10), leukemia inhibitory factor(LIF), lipopolysaccharide-induced chemokine(LIX), monocyte chemoattractant protein-1(MCP-1), macrophage colony-stimulating factor(M-CSF), macrophage inflammatory protein(MIP)-$1{\alpha}$, MIP-$1{\beta}$, MIP-2, Regulated on Activation, Normal T cell Expressed and Secreted(RANTES) and vascular endothelial growth factor(VEGF) were measured. Result : AG significantly inhibited LPS-induced production of TNF-${\alpha}$, MIP-$1{\alpha}$, G-CSF, RANTES, IL-10, and M-CSF from LPS-stimulated RAW 264.7 cells at the concentrations of 50 and 100 ug/mL. AG significantly inhibited LPS-induced production of MIP-$1{\beta}$, MIP-2, GM-CSF, and IL-6 from LPS-stimulated RAW 264.7 cells at the concentrations of 50 ug/mL. AG significantly inhibited LPS-induced production of VEGF from LPS-stimulated RAW 264.7 cells at the concentrations of 100 ug/mL. But AG did not show any significant effect on the production of MCP-1, LIF, LIX, IP-10 and IL-$1{\beta}$ from LPS-induced RAW 264.7 cells. Conclusion : These results suggest that AG has anti-inflammatory effect related with its inhibition of proinflammatory mediators such as TNF-${\alpha}$, MIP-$1{\alpha}$, G-CSF, RANTES, IL-10, MIP-$1{\beta}$, MIP-2, GM-CSF, IL-6, VEGF and M-CSF in LPS-induced macrophages.

호중구 감소증이 합병된 신생아 패혈증에서 Recombinant Human Granulocyte Colony-Stimulating Factor(rhG-CSF)의 투여 용량에 따른 치료 효과 (Therapeutic Effect of Different Doses of Recombinant Human Granulocyte Colony-Stimulating Factor(rhG-CSF) on Neonatal Sepsis Complicated by Neutropenia)

  • 최문영;정연숙;손동우;안효섭
    • Clinical and Experimental Pediatrics
    • /
    • 제45권4호
    • /
    • pp.439-448
    • /
    • 2002
  • 목 적 : 신생아 호중구 감소증이 합병된 신생아 패혈증 환아의 치료에 있어서 부가적으로 rhG-CSF(recombinant human granulocye colony-stimulating factor)를 투여함에 있어서 서로 다른 용량의 rhG-CSF를 투여함으로써 나타나는 신생아 패혈증에 합병된 호중구 감소증의 치료와 환아들의 생존율에 미치는 영향을 평가, 비교하려고 하였다(group I/II형 연구). 방 법: 1995년 10월부터 1996년까지 신생아 호중구 감소증이 합병된 신생아 패혈증 환아는 모두 10명으로 이들에게는 $10{\mu}g/kg$을 피하주사 하였고(rhG-CSF $10{\mu}g/kg$ 투여군), 1996년 10월부터 1997년 9 월까지는 신생아 호중구 감소증이 합병된 신생아 패혈증 환아는 모두 12명으로 이들에게는 rhG-CSF를 $5{\mu}g/kg$ 피하주사 하였다(rhG-CSF $5{\mu}g/kg$ 투여군). 각 군의 호중구 증가 정도와 임상적 결과를 서로 비교하였다. 결 과 : RhG-CSF $10{\mu}g/kg$ 투여군은 조발형 신생아 패혈증 1명과 지발형 신생아 패혈증 9명으로 이루어졌고, 모두에게 호중구 감소증이 합병되었다. rhG-CSF $5{\mu}g/kg$ 투여군은 조발형 신생아 패혈증 1명과 지발형 신생아 패혈증 11명이 대상이 되었고, 이들 모두 호중구 감소증이 합병되었다. 두 군간에 출생체중, 재태주령, 항생제 사용, 신생아 패혈증 시기에 기계적 환기요법 투여, 승압제로 dopamine 투여 또는 다른 지지적 요법의 투여에 있어서 차이가 없었다. rhG-CSF 투여 전의 순 호중구 수(ANC)는 rhG-CSF $10{\mu}g/kg$ 투여군이 $1,065{\pm}89$($mean{\pm}SEM$), $5{\mu}g/kg$ 투여군이 $1,053{\pm}131$로 차이가 없었다. 투여 후의 ANC의 증가는 rhG-CSF $10{\mu}g/kg$ 투여군과 $5{\mu}g/kg$ 투여군에서 각각 투여 후 24시간에 7배, 6배, 투여 후 48시간에 10배, 6배, 투여 후 72시간에 8배, 4배, 투여 후 120시간에 8배, 4배로 투여 전에 비하여 두 군 모두에서 각 시간에 의미 있는 증가를 보였다(repeated measure ANOVA와 Kruskall-Wallis test, within subjects effect). 그러나 두 군 간의 차이는 투여 후 48시간에 ANC 최고치에서만 의미 있는 차이를 보였다(student t-test와 Wilcoxon rank sum test). 단핵구 수도 이 기간 동안 의미 있게 증가하였으나 정상범위를 넘지는 않았다. rhG-CSF $10{\mu}g/kg$ 투여군에서 1명의 환아가 자의 퇴원하였고, 1명의 환아가 사망하여 신생아 패혈증에서 회복하여 문제없이 퇴원한 생존율은 자의 퇴원 환아를 제외한 9명 중 8명으로 88.9%였고, rhG-CSF $5{\mu}g/kg$ 투여 군은 12명 중 10명이 생존하여 생존율은 83.3%였다. 두 군 모두에서 특별한 독성이나 부작용은 관찰되지 않았다. 결 론 : RhG-CSF의 투여는 호중구 감소증이 합병된 극심한 신생아 패혈증 환아에서 호중구의 증가를 일으켰다. 두가지 투여 용량에 따르는 효과는 거의 동일하였으며, 단지 투여 후 48시간에 ANC 최고치에서만 의미 있는 차이가 있었다. 두 군의 생존율은 80%이상이었다. 이와 같은 호중구 감소증이 합병된 신생아 패혈증에서 rhG-CSF의 투여 효과는 골수 억압이나 호중구 소모에 의하여 호중구 감소증이 합병된 신생아 패혈증에서 시기적으로 적절히 투여하면 효과적인 치료를 이룰 수 있다는 것을 시사한다. 향후 rhG-CSF의 효능과 부작용에 대하여 무작위 대조실험이 필요시 된다.